Dr Eliana Barrenho studies the relationship between innovation productivity and health needs, specifically: the role of competition and alliances between firms in the drug innovation process; the health inequalities on drug innovation and disease investment; and the policy landscape on research and development and innovation adoption in the health systems.
Her recent work examines the effect of social networks and national guidelines on the diffusion of new technologies in the English National Health System.
She holds a PhD in Health Economics from Imperial College London. As well as the Business School, she has held positions at Paris School of Economics, the University of York, London School of Economics and Universidade Nova de Lisboa. She is a Research Affiliate at Chaire Hospinnomics and at the Nova Health Care Initiative.
et al., 2021, The importance of surgeons and their peers in adoption and diffusion of innovation: an observational study of laparoscopic colectomy adoption and diffusion in England, Social Science and Medicine, Vol:272, ISSN:0277-9536
et al., 2017, Vertical and horizontal equity of funding for malaria control: a global multi source funding analysis for 2006-2010, Bmj Global Health, Vol:2, ISSN:2059-7908
Pires Barrenho EA, Miraldo M, Smith PC, 2017, Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries., ISSN:1744-6783
Jacobs R, Barrenho E, 2011, How to interpret different results for CRHTT data reply, British Journal of Psychiatry, Vol:199, ISSN:0007-1250, Pages:249-249